AuNPs are being widely investigated for targeted delivery of drugs, genetic materials, antigens, and diagnostic agents to the brain. [ 7 ] For example, in combination with radiation, AuNPs have proven successful at dissolving deposits of beta-amyloid, the protein involved in Alzheimer's disease. [8] [9] [10] [11] Because of the wide biomedical applications of AuNPs, human exposure to AuNPs will be increasingly likely, which warrants careful evaluation of their toxicological effects. AuNPs have been described by most studies as nontoxic, [12] [13] [14] [15] but some studies have found them to be toxic. [16] [17] [18] [19] [20] [21] [22] AuNPs with 1.4-1.5 nm in diameter (Au 55 ) have been found to be highly toxic to (5 
mC) and a corresponding increase in global DNA hydroxymethylation (5 hmC) of the hESC's DNA in only 24 h. This work identifi es a type of AuNPs highly toxic to hESCs and demonstrates the potential of hESCs in
predicting nanotoxicity and characterizing their ability to alter the DNA methylation and hydroxymethylation patterns in the cells.
Introduction
Nanotoxicology is an emerging discipline studying the interference of engineered nanomaterials with the functions of cellular and extracellular nanomachineries. [ 1 ] The accelerated pace of clinical trials and commercialization of nanomaterials places increased demands on toxicological evaluations of engineered nanomaterials. [ 2 ] There is an urgent need to develop predictive and validated nanotoxicological assessment methods for nanomaterials due to their unique size small 2016, 12, No. 5, 631-646 cells. [ 18, 23 ] A few studies have shown that chronic exposure to AuNPs might interfere with brain function. For example, exposure to high concentrations of 20 nm AuNPs was found to increase the proliferation of human neurosphere-derived neural precursor/pregenitor cells (NPCs) [ 24 ] and induce oxidative stress in a mouse immortalized NPC line. [ 25 ] In rodent models, intraperitoneal injections of 17-20 nm AuNPs resulted in learning and memory defi cits associated with elevated dopamine levels and decreased serotonin levels, [ 26 ] as well as increased brain expression levels of markers of oxidative stress, apoptosis, and infl ammation. [ 27 ] More recently, cultured mouse hippocampal CA1 neurons were shown to be more excitable when exposed to 5-40 nm AuNPs. [ 28 ] Taken together, these data demonstrate that AuNPs as tools for neuromedicine should be carefully evaluated since they may adversely alter neuronal differentiation, synapse formation, and functional plasticity (which affect memory and learning) in a sizedependent manner.
Currently, there are no systematic methods to predict toxicological effects of AuNPs on human health. A majority of neurotoxicological assessments are conducted in vitro using immortalized cell lines with standard toxicological assays such as the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) (measurement of mitochondrial enzymatic activity) and (lactate dehydrogenase (LDH) (measurement of cell membrane disruption) assays with short exposure time (usually limited to within 48 h). One shortcoming of standard in vitro toxicity assays, however, is that the potential interference of nanoparticles with embryonic development or stem cell differentiation cannot be clearly addressed. On the other hand, it is often diffi cult to correlate outcomes from animals to humans based on in vivo tests. Human embryonic stem cells (hESCs) [ 29 ] and their subsequent differentiation into NPCs and neurons have enabled researchers to establish pluripotent cell-based models to study developmental neurotoxicology. This process mimics aspects of the early stages of human brain development, giving us a unique opportunity to identify the effects of exposure to nanomaterials on neural specifi cation. Though mouse ESCs were recently used to evaluate the neurotoxicity of AuNPs, [ 30, 31 ] hESCs have yet to be applied for nanotoxicological testing.
This paper explores the use of hESCs for neurotoxicity testing of AuNPs and dendrimers. It describes the morphological and epigenetic effects of AuNPs of three core sizes, 1.5, 4, and 14 nm, on the neuronal differentiation of hESCs. The 1.5 nm AuNP (AuNP1.5) was chosen because AuNPs of this size have been found to be highly toxic to cells. [ 18, 23 ] AuNP4 and AuNP14 are within the size range widely used for targeted drug delivery applications including those targeting the brain. [ 5, 6 ] The nanoparticle size and surface chemistry were characterized by UV-vis, TEM, and zetasizer. We show that AuNPs have size-dependent differential effects on the viability, pluripotency, and neuronal differentiation potentials of hESCs, AuNP1.5 being highly toxic. In addition, we show that exposure to certain sized AuNPs modifi es the DNA methylation and hydroxymethylation profi les of hESCs.
www.small-journal.com dures in the literature. The detailed procedures are described in the Experimental Section and only briefl y summarized here. Ultrasmall AuNP1.5 was synthesized by modifying a literature procedure using a mild reductant tert -butylamineborane to slow down the reduction rate of AuCl(PPh 3 ) precursor. [ 32 ] AuNP1.5 was capped by mercaptosuccinic acid (MSA) following the ligand exchange reaction. [ 33 ] AuNP4 capped by MSA was synthesized by following a literature procedure. [ 34 ] Citrate-capped AuNP14 was synthesized by using the Turkevich method. [35] [36] [37] [38] For comparison with the AuNPs, two half-generation dendrimers with carboxyl termination G0.5 and G1.5 were used.
The nanoparticles were characterized by TEM with energy-dispersive spectroscopy (EDAX), zetasizer, and UV-vis spectroscopy. Figure 1 A shows the TEM images of synthesized AuNPs. Their diameters were determined to be 1.5 ± 0.1 nm (AuNP1.5), 4.2 ± 0.5 nm (AuNP4), and 13.6 ± 0.4 nm (AuNP14), respectively. The various AuNPs were thus identifi ed by their TEM measured diameters. Figure 1 B shows the TEM EDAX spectra of AuNP1.5 before and after the ligand exchange reaction. The phosphorus peak at 2.013 eV was replaced by the sulfur peak at 2.307 eV confi rming the exchange reaction. The gold peak was unchanged at 2.120 eV.
When AuNP4 and AuNP14 were added to the hESC culture medium, we observed aggregation of the nanoparticles from the disappearance of the red color associated with stabilized AuNPs. To prevent this, we incubated the nanoparticles with bovine serum albumin (BSA) prior to their addition to the culture medium as BSA has been shown to be effective in preventing nanoparticle aggregation in culture medium. [ 39, 40 ] BSA coating was proven to be effective in preventing AuNPs from aggregation in the hESC culture medium (see Section 2.2). The nanoparticle size measurements from dynamic light scattering (DLS) ( Figure S1 , Supporting Information) are consistent with the expected sizes of the AuNPs and dendrimers. After applying the BSA, an increase in particle hydrodynamic radius of 4-6 nm was observed for AuNP4 and AuNP14 indicating the formation of the corona (BSA has the following molecular dimensions 3 nm × 3 nm × 8 nm. [ 39 ] The particles retained their negative charges after being coated with BSA. We were not able to determine the size of AuNP1.5, G0.5, and G1.5 after incubating with BSA due to their extreme small sizes. The UV-vis spectra of the AuNPs after coating with BSA showed no shift in the absorption peak position in the range of 500-520 nm dispersed either in deionized water or phosphate-buffered saline (PBS) buffer further supporting the stabilization effect of BSA ( Figure S2 , Supporting Information). In contrast to AuNP4 and AuNP14, AuNP1.5 does not absorb light in the 500-520 nm range ( Figure S2a , Supporting Information) because ultrasmall AuNPs of 1-2 nm are no longer metallic but exhibit discrete electron excitations. [ 41 ] 
AuNP Size Effect on hESC Viability
Here, we sought to determine the infl uence that AuNPs of various sizes may have on hESCs and their neuronal specifi cation. We started by examining the effects that AuNP exposure has on the viability of hESCs. We fi rst verifi ed the effi cacy of the BSA-coating procedure at preventing AuNP aggregation in the hESC culture medium. The culture medium maintained its red color when BSA-coated AuNPs were introduced indicating the AuNP colloidal stability. of AuNP1.5, AuNP4, or AuNP14. We chose to express particle dosage in mass concentration (e.g., µg mL −1 ) as in a majority of publications. However, considering the importance of particle surface area concentration (e.g., cm 2 mL −1 ) and dose per cell number, [ 42 ] we also listed the corresponding dosages in Table 1 for various sized AuNPs. The cell density of 100 000 cells mL −1 was used in the calculations. Colonies exposed to AuNP1.5 exhibited altered morphology suggestive of cell death. As shown in Figure 2 A, no signifi cant AuNP aggregates were visible for any size of BSA-coated AuNPs tested, confi rming earlier reports. [ 39, 40 ] To identify the potential AuNP toxicity, hESCs were exposed to 10 µg mL
AuNPs, largely above the nontoxic range [ 5 ] for 24 h. At the end of exposure with AuNP4 and AuNP14, no remarkable differences in the growth and morphology of hESC colonies were observed compared to control cultures (Figure 2 A) . In contrast, cells in AuNP1.5-treated hESC colonies exhibited loss of cohesiveness, rounding up, and detachment, suggesting ongoing cell death (Figure 2 A) . Similar time-course and severity of AuNP1.5-induced cell loss were observed when hESCs were cultured on gelatin-coated plates instead of MEFs, suggesting a direct toxic effect of AuNP1.5 on hESCs (data not shown). Trypan blue assays, which stain dead cells, at the end of the 24 h treatment revealed statistically signifi cant differences in the viability of hESCs between the different experimental groups ( p < 0.001) (Figure 2 B) . Thus, whereas no change in viability was observed among control, AuNP4-( p = 0.79), and AuNP14-( p = 0.89) treated cultures, a statistically signifi cant 88% decrease in the number of viable hESCs was observed following treatment with AuNP1.5 ( p < 0.001) (Figure 2 B) . Assessment of hESC viability using the MTT viability assay, a measure of mitochondrial function, provided comparable results with a statistically signifi cant 85% decrease ( p = 0.028) in cell viability in AuNP1.5-treated hESCs compared to controls (Figure 2 C) .
We then analyzed the sublethal range of exposure to AuNP1.5 by assessing the viability of hESCs treated for 4 d with six different concentrations ranging from 0.001 to 10 µg mL −1 (Figure 2 D) . The Trypan blue exclusion assay revealed a dose-dependent decrease in hESC viability, with concentrations of 0.1 and 1 µg mL −1 resulting in a signifi cant 24% ( p = 0.004) and 43% ( p < 0.001) reduction, respectively (Figure 2 D) . Almost no hESCs survived following exposure to 10 µg mL −1 AuNP1.5 ( p < 0.001) (Figure 2 D) . We found that the lowest AuNP1.5 concentrations of 0.001 and 0.01 µg mL −1 slightly reduced hESC viability compared to control cultures, but these differences did not reach statistical signifi cance ( p > 0.05). The IC 50 value, i.e., the concentration necessary to kill 50% of the cells, measured in this 4 d exposure paradigm was 1.45 µg mL −1 (or 0.0706 × 10 −6 m ). MTT viability was also signifi cantly reduced after exposure to 10 µg mL −1 ( p = 0.007) (Figure 2 D) . A nonsignifi cant trend ( p = 0.11) toward reduced cell viability at the 1 µg mL −1 concentration was also observed with the MTT assay for which the IC 50 value was 1.03 µg mL −1 .
In comparison, viability of hESCs was tested against BSA-treated G0.5 and G1.5 dendrimers with the same carboxyl surface group and in a close hydrodynamic size range as AuNP1.5 ( Figure S1 , Supporting Information). We compared the viability of hESCs exposed for 24 h to AuNP1.5 or G0.5 and G1.5 dendrimers at a concentration of 10 µg mL −1 . As shown in Figure 2 E using the Trypan blue assay, the percentage of viable hESCs after exposure to dendrimers of both sizes was not different from that observed in control cultures. However, as previously observed, no hESCs survived treatment with AuNP1.5 ( p < 0.001), suggesting that it is the chemical nature of gold that likely plays a role in AuNP1.5-induced cytotoxicity.
AuNP Cell Uptake by hESCs
Size, shape, surface chemistry, and dosage are factors that may affect the uptake of AuNPs by cells. [ 5 ] The main route for AuNP cellular entry is through endocytosis and it depends on the size, shape, and surface chemistry of AuNP. [ 13, 43 ] As shown in Figure 2 A, intracellular accumulation of AuNP4 and AuNP14 could clearly be detected by optical microscopy in cultures of hESCs grown on MEFs after a 24 h exposure to 10 µg mL −1 concentration. Using DAPI (4′,6-diamidino-2-phenylindole) staining to visualize the differences in nuclear chromatin patterns that exist between MEFs and hESCs, [ 44, 45 ] we observed that the nuclei of AuNP-positive cells displayed the bright fl uorescent heterochromatin foci, characteristic of both proliferating and senescent MEFs [ 45 ] ( www.small-journal.com shown), AuNP4, or AuNP14 could be observed in hESCs (Figure 3 B,C). While we cannot exclude that cell death being a factor preventing active transport of AuNP1.5 at 10 µg mL −1 , we observed no visible intracellular entry of AuNP1.5 at sublethal dosages.
This peculiar observation prompted us to further examine the uptake effi ciency of AuNPs by MEFs and hESCs. To this end, we treated MEFs and hESCs with either vehicle (control) or 10 µg mL [ [46] [47] [48] [49] AuNP14-exposed hESCs exhibited a cellular ultrastructure similar to that observed in control cells, and no AuNP14 could be clearly observed (Figure 4 E), suggesting that no intracellular AuNP uptake had occurred in hESCs. Because staining of the sections may make it diffi cult to discriminate the AuNP from the electron-dense glycogen granules, we also small 2016, 12, No. 5, 631-646 Figure 2 . Exposure of hESCs to AuNPs. A) WA09 hESC cell colonies on MEF feeder layer following 24 h exposure to vehicle, or 10 μg mL −1 of AuNP1.5, AuNP4, and AuNP14. Only colonies exposed to AuNP1.5 exhibited altered morphology suggestive of cell death. Arrows indicate MEFs with visible intracellular uptake of AuNPs in the case of AuNP4 and AuNP14. AuNP1.5 was too small to be seen. The scale bar is 160 μm in the bright fi eld microscopic images. B) Cell viability analysis of hESCs exposed for 24 h to 10 μg mL −1 of the different sized AuNPs using Trypan blue assay. The percentage of viable cells [(total number of cells − number of nonviable dark-blue stained cells)/(total number of cells) × 100] was signifi cantly decreased following exposure to AuNP1.5. Histogram values are means ± SEM. Statistical signifi cance compared to the vehicle control group is designated as (***) ( p < 0.001; n = 3, one-way ANOVA). C) Measurement of mitochondrial activity in hESCs exposed for 24 h to 10 μg mL −1 of the different sized AuNPs by the MTT assay. A decrease in mitochondrial enzymatic activity was observed between the vehicle and the AuNP1.5 experimental groups. Histogram values are means ± SEM. Statistical signifi cance compared to the vehicle control group is designated as (*) ( p = 0.028; n = 3, one-way ANOVA). D) Dose-response curves for the survival of hESCs exposed to AuNP1.5 for 4 d using Trypan blue and MTT assays. Statistical signifi cances compared to the vehicle group are noted as (***) ( p < 0.001; n = 3) and as (**) ( p < 0.01; n = 3). E) Cell viability analysis of hESCs exposed for 24 h to 10 μg mL −1 of AuNP1.5 and dendrimers G0.5 and G1.5 using Trypan blue assay. Histogram values are means ± SEM. Statistical signifi cance compared to the vehicle control group is designated as (***) ( p < 0.001; n = 3, one-way ANOVA).
analyzed unstained sections by TEM. No AuNP could clearly be observed in AuNP-exposed versus control hESCs ( Figure  4 F,G). Combining the data from optical and electron microcopies we conclude that AuNP14 was taken up readily by MEFs but not by hESCs.
AuNP Effect on hESC Pluripotency
Next, we sought to determine if AuNP exposure affects the capabilities of hESCs to generate ectodermal, mesodermal, and endodermal derivatives. The pluripotency of hESCs enables them to differentiate into multiple tissue types. To this end, we passively differentiated hESC-derived embryoid bodies (EBs) for two weeks in basic fi broblast growth factor (FGF2)-free stem cell medium, while exposing them to either AuNP or vehicle. The concentration for AuNP4 and AuNP14 was 10 µg mL −1 , while a sublethal dosage of 0.6 µg mL −1 was used for AuNP1.5. As shown in Figure 5 , quantifi cation of marker mRNAs indicated that there were no statistically signifi cant differences in the expression levels of NCAM ( 
AuNP Effect on the Neuronal Differentiation of hESCs
To examine the effects of exposure to various sized AuNPs on the neural differentiation of hESCs, we generated EBs and maintained them throughout the entire neural differentiation protocol (19 d) in the presence of vehicle or 10 µg mL −1 AuNP1.5, AuNP4, or AuNP14. The presence of AuNP4 and AuNP14 in the medium did not prevent the formation of EBs, which appeared morphologically similar to those generated from vehicle-exposed EBs ( Figure 6 ). In contrast, AuNP1.5-exposed hESCs did not form EBs but rather rapidly disintegrated into single cells within 48 h of treatment, so that by day 3, no EBs survived ( Figure 6 ). Therefore, following experiments were carried out using a 0.6 µg mL −1 (EC30) concentration for AuNP1.5, which allowed the formation of EBs. During neural differentiation, both control and AuNP1.5-treated EBs were able to generate neural rosettes ( Figure 6 ). However, the neural rosettes formed by AuNP1.5-exposed EBs were small, exhibiting a dark aspect (Figure 6 ), and did not survive. The data suggest that even at sublethal dosage AuNP1.5 causes adverse effect on neuronal differentiation of hESCs.
Even though NPCs generated from AuNP4-and AuNP14-treated hESCs appeared similar to those obtained from control hESCs, we further verifi ed their capability to differentiate into neurons by using previously published protocol. [ 50 ] By day 21, about 15.1 ± 2.3% of MAP2-positive neurons were observed in control cultures. No statistically signifi cant differences ( p = 0.912) in the percentage of MAP2-positive neurons were observed between NPC cultures derived from AuNP4-(16.3 ± 3%) or AuNP14-(14.7 ± 2.6%) hESCs. We then analyzed the complexity of the differentiated neurons by quantitatively measuring several morphological parameters. Sholl analysis ( Figure S3 , Supporting Information) indicated no remarkable differences in the average sum of crossings ( p = 0.21) ( Figure S3A ,B, Supporting Information), average neuritic length ( p = 0.45) ( Figure S3C , Supporting Information), or average number of branchings ( p = 0.25) ( Figure S3D , Supporting Information) between control hESCs and AuNP-treated hESCs. Taken together, these data show that exposure to AuNP4 or AuNP14 of hESCs does not alter the neuronal differentiation capabilities of their derived NPCs.
AuNP Effect on hESC-Derived NPCs
To better understand the neurotoxic effects of AuNP1.5 on the formation of neural rosettes, we examined the direct effects of AuNP1.5 on the survival of NPCs. To this end, proliferating hESC-derived NPCs were exposed for 3 d to vehicle or 10 µg mL −1 of AuNPs, and immunostained for the neural marker Nestin and the DNA marker DAPI. While cultures treated with vehicle, AuNP4, and AuNP14 exhibited numerous NPCs, those exposed to AuNP1.5 were almost completely depleted of cells ( Figure 7 A-H). There was a signifi cant 54-fold increase ( p = 0.02) in the number of pyknotic nuclei (condensed chromatin state that precedes apoptosis) in AuNP1. www.small-journal.com
AuNP Effect on hESC Epigenetics
We hypothesized that some of the physiological effects of AuNP exposure can be mediated by changes in the methylcytosine (5 mC) profi le of the genome. Therefore, we investigated the global 5 mC status of the genome using a 5 mC-immunoprecipitation-based colorimetric assay in hESC exposed to sublethal dosage of 1 µg mL −1 AuNP1.5, 10 µg mL −1 AuNP4, or 10 µg mL −1 AuNP14 for 24 h. We also chose 10 µg mL using embryonic stem cells. [ 51 ] This concentration avoids exposing cells to an excessive amount of buffer. We observed a marked reduction of 5 mC levels 24 h after AuNP exposure irrespective of AuNP size ( Figure 8 A) . Interestingly, exposure to AuNP4 showed the most dramatic decrease in 5 mC levels (Figure 8 A) . This decrease was coupled with an increase in hydroxymethylcytosine (5 hmC), which is consistent with 5 hmC being the fi rst step in the demethylation process of DNA (Figure 8 B; see Discussion). We performed a two-sample t -test, assuming equal variances, to determine if the reported differences were statistically signifi cant. www.small-journal.com result, we looked at the locus specifi c methylation profi le of hESCs exposed to AuNP1.5, AuNP4, and AuNP14 using the HM450K array, which measures the DNA methylation levels at over 480 000 CpG sites in the human genome (see the Experimental Section). Principle component analysis (PCA) of the matrix of normalized beta values for all sample indicated the hESCs treated with AuNP4 clustered separately along principle component 1 compared to the nontreated hESCs, and hESCs treated with AuNP1.5 and AuNP14 (Figure 8 C) . All of the samples also showed separation along principle component 2, suggesting large variability between replicates (Figure 8 C) . In agreement with the PCA, we did not observe any signifi cant association of 5 mC levels for single CpG sites (at an FDR corrected cutoff of p < 0.05) with exposure to either 1 µg mL −1 AuNP1.5 or 10 µg mL −1 AuNP14 (Figure 8 D) . However hESCs treated with 10 µg mL −1 AuNP4 showed a large number of exposure-dependent genome-wide associations between 5 mC levels for single CpG sites, as illustrated by the q -q plot (Figure 8 D) . A q -q plot is a plot of the quantiles of the fi rst data set against the quantiles of the second data set. By a quantile, we mean the fraction (or percent) of points below the given value. That is, the 0.2 (or 20%) quantile is the point at which 20% of the data fall below and 80% fall above that value. Previous studies have indicated that the HM450K array is able to detect 0.20 or 20% difference in CpG methylation (Deltabeta) with a confi dence of ≈95%. At an exposure effect size ≥ Ϳ0.20Ϳ or 20%, FDR corrected p -value ≤ 0.05, 31 311 single CpG sites showed a decrease in beta values (negative Deltabeta) on exposure to AuNP4 (Figure 8 E) . This result confi rms our previous observation that treatment of hESCs with AuNP4 cause global DNA demethylation.
Discussion
This is one of the fi rst studies to demonstrate the use of hESCs for assessing nanotoxicology, specifi cally, the effect of AuNPs on the viability, pluripotency, neuronal differentiation, and DNA methylation of hESCs. Some signifi cant advantages in using hESCs compared to other (e.g., animal-derived) systems are that (1) they have unlimited self-renewal capabilities and can be grown indefi nitely in the laboratory; (2) they can differentiate into a variety of specialized cell types, such as neurons over a longer period of time; (3) they preclude interspecies variability, making them a better model to predict human response to toxins; and (4) subtle changes in cell functionality rather than cell death can be tested on nanomaterials of low toxicity such as majority of AuNPs. This study contributes an hESC-based assay to the study of human developmental neurotoxicology. The differentiation of hESCs into neurons mimics aspects of the early stages of human brain development. Cytotoxicity to hESCs caused by AuNP1.5 therefore implies that such ultrasmall AuNPs may be toxic to humans (especially considering the size effect on tissue distribution and ability to cross the blood-brain barrier) and their use be further regulated.
Of the three AuNP sizes studied, only AuNP1.5 shows toxicity to hESC viability and differentiation into EBs. The IC 50 value measured during 4 d exposure of AuNP1.5 is 0.0706 × 10 −6 m . In comparison, the IC 50 (3 d test) for a common chemotherapeutic agent, cisplatin, is 0.45 × 10 −6 m tested on fi broblast CCD-919Sk cells, 7.93 × 10 −6 m on cervical cancer HeLa cells, and 26.10 × 10 −6 m on bone MCT3T3-E1 cells. [ 18 ] It shows that AuNP1.5 can be as or more toxic than chemotherapeutic drugs. Indeed, some have suggested that such AuNPs could be used for cancer treatment if toxicity to normal cells can be controlled. [ 1, 52 ] small 2016, 12, No. 5, 631-646 Figure 6 . Formation of embryoid bodies and neural rosettes by control and AuNP-exposed hESCs. Exposure to 10 μg mL −1 AuNP4 or AuNP14 did not affect the capability of hESCs to generate EBs and neural rosettes, compared to control cells (vehicle). In contrast, cells exposed to 10 μg mL −1 AuNP1.5 were not able to form EBs and died within 2 d of exposure. When treated with a lower concentration of 0.6 μg mL −1 AuNP1.5, hESCs were able to form EBs, but exhibited a decrease in growth, which resulted in the formation of small sized neural rosettes compared to control cells. Bars: 150 μm (EBs day 1), 100 μm (in EBs day 2 and neural rosettes).
Our study also found that dendrimers of generation 0.5 and 1.5 with similar size and carboxylic acid termination to AuNP1.5 do not exhibit cytotoxicity to hESCs. However, one must consider differences beyond a simple size comparison. Dendrimers of such early generations (G0.5 and G1.5) behave more like an open prolate ellipsoid than a hard sphere. [ 53, 54 ] In addition, the interaction between amphiphilic dendrimers with hydrophobic core and hydrophilic surface may interact with cell membranes differently from hydrophilic AuNPs with fully protected surface.
Though our study is not the fi rst one to show cytotoxicity of ultrasmall AuNPs of the cluster structure Au 55 , we want to point out some key new fi ndings based on our results. First, we briefl y summarize previous studies on sizedependent cytotoxicity of AuNPs both in vitro (e.g., using melanoma cells, cervix carcinoma cells, mouse fi broblasts, and mouse macrophages) [ 18, 23, 55 ] and in vivo (using zebrafi sh embryos). [ 56 ] Au 55 cluster with a diameter of 1.4 nm capped by triphenylphosphine monosulfonate (TPPMS), denoted as Au1.4MS, was found highly toxic to a number of human cancer and healthy cell lines. [ 18 ] For example, the IC 50 value of Au 55 was determined to be 0.62 × 10 −6 m for CCD-919Sk fi broblast cells measured at 24 h. Au1.4MS was found to cause necrosis by oxidative stress and mitochondrial damage while AuNPs of 15 nm in size are nontoxic. [ 23 ] The same study also showed that when the phosphine ligand was replaced with a thiol ligand, glutathione, Au 55 cytotoxicity was greatly reduced. [ 23 ] The authors attributed the toxicity of Au1.4MS to weak phosphine/metal binding that allows highly electronegative gold atoms to interact directly with biological targets. However, in our study, we found that even thiolate-capped Au 55 is toxic to both MEFs and hESCs. In addition, the low IC 50 of hESCs suggests that hESCs may be more sensitive to Au 55 than other cell types.
The second key fi nding of this study is hESC uptake of AuNPs is much more limited than other cell types reported in the literature. [ 13, 43, 57 ] We found little evidence of intracellular uptake of AuNP4 and AuNP14 by hESCs while at the same time these nanoparticles were located readily in the cytoplasm of MEFs, despite their being lethally irradiated (which is a standard treatment for feeder cells). Our GoldEnhance data suggest that AuNP1.5 may not be taken www.small-journal.com up by hESCs, which points to a possibility that AuNP1.5 imposes its adverse effects on hESC survival and neuronal differentiation without signifi cant intracellular uptake. In the literature, several mechanisms of AuNP cytotoxicity have been proposed. One attributes AuNP cytotoxicity to Au 55 binding to the major groove of B-DNA thereby interfering with DNA transcription in the cell nucleus. [ 18 ] The second mechanism is the continuous generation of intracellular reactive oxygen species (ROS), such as superoxide radicals, hydrogen peroxide, and hydroxyl radicals, by Au 55 reaction small 2016, 12, No. 5, 631-646 Figure 8 . Exposure to 10 μg mL −1 AuNP4 for 24 h causes global demethylation of genomic DNA. A) Global 5 mC levels measured using MethylFlash Methylated DNA Quantifi cation Kit. Genomic DNA from AuNP4 treated hESCs shows an observable decrease in 5 mC, though the p -value from two sample t -test assuming equal variances is 0.062. B) Global 5 hmC levels measured using MethylFlash Hydroxymethylated DNA Quantifi cation Kit. Genomic DNA from AuNP4 treated hESCs shows an observable increase in 5 hmC, though the p -value from two sample t -test assuming equal variances is 0.093. C) PCA on normalized beta matrix indicating that the AuNP4 cluster separately from the other treatments (AuNP1.5 and AuNP14) and the nontreated controls. D) q -q plot for genome wide association analysis using fi xed effect model for AuNP1.5, AuNP4, and AuNP14. The results show a large number of CpG sites (red = increase, green = decrease) where called to be signifi cant differentially methylated at an FDR corrected p -value cutoff < 0. with dioxygen. [ 23 ] ROS subsequently can cause oxidation of biomolecules. The third mechanism is Au 55 's interactions with cell membrane proteins, for example, by blocking membrane ion channel [ 58 ] or reducing free thiols on the cell membrane. [ 59 ] In another study of AuNP surface functionalities on zebrafi sh embryonic gene expression, 2-mercaptoethanesulfonic acid (MES)-capped 1.5 nm AuNPs were found to affect ion channel transport mechanism signaled by misregulated gene expression. [ 60 ] Our data of hydrodynamic sizes of AuNP1.4, G0.5, and G1.5 (i.e., diffi culty in measuring their sizes even in the presence of BSA) suggest that BSA could not form a corona around these ultrasmall nanoparticles due to steric constraints. Taken all together, our data suggest that AuNP1.5 interferes with membrane functions due to lack of BSA surface modifi cation as well as their larger surface area to volume ratio. Further studies are necessary in order to clearly elucidate the mechanism underlying Au 55 toxicity to hESCs and their differentiation. Finally, the leaching of ionic gold is also a possibility that cannot be ruled out. However, others have shown that gold nanoparticles of smaller sizes, 0.8 and 1.2 nm in diameter, are much less toxic than 1.4 nm gold. [ 55 ] This seems to argue against a simple ion leaching mechanism.
A third major fi nding from this study is that AuNP4 causes greater than 20% decrease in DNA methylation at over 31 000 CpG sites, which represents over 6% of the probes on the HM450K array. There were no CpG sites that had a greater than 20% increase in DNA methylation, which suggests that AuNP4 somehow leads to a global decrease in DNA methylation by some unknown mechanism. This is surprising because AuNP4 showed no toxicity in our hESC assays, so it suggests that AuNP4 might actually be beneficial to these cells by decreasing the levels of DNA methylation. Stem cells generally exhibit a much lower level of DNA methylation level than somatic cells. Consistent with the idea that AuNP4 causes a global decrease in DNA methylation, colorimetric assays using 5 mC antibodies showed a trend for a decrease in DNA methylation. Similarly, colorimetric assay with 5 hmC antibodies showed a trend for an increase in DNA hydroxymethylation. Since 5 hmC is generated by teneleven-tranlocase (TET) family proteins, that are involved in DNA demethylation, [ 61 ] we speculate that AuNP4 stimulates the activity of one or more TET proteins and this ultimately leads to a global decrease in DNA methylation.
Conclusions
This work described AuNPs of 1.5, 4, and 14 nm in core size on hESC viability, cell uptake, pluripotency, neuronal differentiation into EBs and NPCs, and epigenetic modifi cations to its DNA. AuNPs were used as model nanoparticles due to their versatile surface chemistry, ease of imaging, and tunability for targeted drug/imaging agent delivery. We found that hESC colonies exposed to 1.5 nm MSA-capped AuNPs exhibited loss of cohesiveness, rounding up, and detachment suggesting ongoing cell death. The hESCs exposed to 1.5 nm AuNPs did not form EBs but rather rapidly disintegrated into single cells within 48 h of treatment. Cell death caused by 1.5 nm AuNPs also occurred in the treatment with hESCderived neural precursor/progenitor cells. None of the other nanoparticles exhibited toxic effects on the hSECs or their derivatives in experiments lasting as long as 19 d. In contrast to some reports, we found that Au 55 capped by the strongly binding thiolate could still be toxic to cells. Our data suggest that hESC uptake of nanoparticles may be different from other cell types as we did not observe signifi cant amount of AuNPs inside the hESCs while AuNPs were clearly present inside the MEF feeder cells. Our data also show that 4 nm AuNPs lead to a global decrease in DNA methylation and may benefi t cells by decreasing the levels of DNA methylation. In conclusion, this work identifi es a type of AuNPs highly toxic to hESCs and demonstrates the potential of hESCs in predicting neurotoxicity of nanoparticles. This work could ultimately impact consumers, patients, and manufacturing workers of products containing nanoparticles.
Experimental Section
Reagents : Gold(III) chloride trihydrate (HAuCl 4 ·3H 2 O, 99% metal trace), chloro(triphenylphosphine)gold(I) (AuCl(PPh 3 ), 97%), sodium citrate tribasic dehydrate (≥99%), MSA (97%), borane tert -butylamine complex (97%), sodium borohydride (NaBH 4 ) (98%), polyamidoamine (PAMAM, ethylenediamine core) dendrimer G0.5 (powder) and G1.5 (methanol solution), and bovine serum albumin (BSA, 98%) were all purchased from Sigma-Aldrich. Sodium hydroxide (98%) was purchased from Fisher Scientifi c.
AuNP Synthesis : The chemical structures of the nanoparticles used in this study are shown in Scheme . The number corresponds to the average AuNP diameter in nanometer measured by TEM. Thiolate-capped 1.5 nm ultrasmall nanoparticles (AuNP1.5) were synthesized by modifying a literature procedure. [ 32 ] The Au(I) precursor AuCl(PPh 3 ) (0.375 mmol) was partially dissolved in 21 mL ethanol at room temperature under vigorous stirring (600-800 rpm). Tertbutylamine-borane (3.75 mmol) was used as a mild reducing agent, and 2 h after its addition, MSA (0.15 mmol) was added to control the particles size. [ 33 ] Mercapto-alkyl acids have been found to be effective in stabilizing ultrasmall AuNPs in aqueous solution.
The fi nal AuNP ethanol solution was washed and purifi ed by ultracentrifugation using MW10000 Amicon centrifuge tubes in deionized water repeatedly. MSA-capped AuNP4 were synthesized as following by modifying a literature procedure. [ 34 ] A 500 mL aqueous solution con- Citrate-capped AuNP14 were synthesized by using the Turkevich method. [35] [36] [37] [38] In a typical synthesis, a 500 mL aqueous solution containing 0.25 × 10 −3 M HAuCl 4 ·3H 2 O was heated to boil and then 175 mg of sodium citrate dissolved 30 mL water solution was directly poured into the reaction mixture. The color of the reaction turned gray, pink, and fi nally wine-red. After adjusting the pH, AuNP14 were coated with BSA as described above for AuNP4.
To apply the BSA coating, 10 mg of the nanoparticle dissolved in 10 mL deionized water was incubated overnight with 400 mg BSA.
AuNP Characterization : Varian Cary 50 UV-vis absorption spectroscopy was used to determine AuNP sizes, based on the BeerLambert law, with a scan range of 200-800 nm.
TEM images of AuNPs were taken on JEOL JEM-2010. The samples were prepared by placing a droplet of the AuNP solution on a Formvar-coated copper TEM grid. Excess liquid was removed by a piece of fi lter paper under the grid and dried in the air. The working voltage was 200 keV and the current was 109 mA. At least 50 particles were measured on the same sample to yield an average particle size.
DLS and zeta potential were measured using a Malvern Nano-ZS. A 1 mL solution was transferred to a 2.0 mL polystyrene cuvette. The Z-average hydrodynamic diameter (HD), polydispersity index (PDI), and zeta potential were measured at 25 °C. 15 scans were performed in each measurement. The backscattering angle Θ was fi xed at 172° with a laser wavelength λ = 633 nm. The size measurement range was set between 1 nm and 6 μm. HD is a function of the diffusion coeffi cient ( D ), temperature ( T ), and viscosity ( η ) according to the Stokes-Einstein equation:
, where k is Boltzmann constant, T is 25 °C, and D was obtained from autocorrelation function via the cumulant fi tting. The electrophoretic mobility of the nanoparticles was measured using the laser Doppler velocimetry and phase analysis light scattering technique of the Malvern Zetasizer. The electrophoretic mobility was converted into zeta potential using the Smoluchowski equation using the Malvern software. [ 62 ] Human Embryonic Stem Cell Cultures : The NIH-approved and registered WA09 hESC line (passages 26-32; WiCell Research Institute, Madison, WI, USA) [ 63 ] was maintained in a humidifi ed incubator at 37 °C with 5% CO 2 as previously described. [ 64 ] Briefl y, cells were grown on a feeder layer of irradiated mouse embryonic fi broblasts (GlobalStem, Rockville, MD, USA) in hESC culture medium made of 20% knockout serum replacement, 2 × 10 MTT Assay : hESCs were cultured in phenol red-free culture medium and plated at a density of 100 000 cells per well of a 12-well plate. At the end of AuNP exposure, the medium was supplemented with 0.5 mg mL −1 of MTT (Sigma-Aldrich, St Louis, MO) freshly prepared in PBS, and cells were incubated in the dark at 37 °C for 3 h. MTT-formazan crystals were then solubilized for 15 min, at room temperature in dimethyl sulfoxide (DMSO). Absorbance was measured at 590 nm using a spectrophotometer, and cell survival was expressed as a percentage of absorbance relative to that of control samples. Data were obtained from three separate experiments. Uptakes Studies by TEM : The cellular uptake of AuNPs was assessed on MEFs and undifferentiated WA09 cells (passage 32) exposed to vehicle or 10 μg mL −1 AuNP14 for 48 h. At the end of exposure, cells were washed and fi xed in 2.5% glutaraldehyde (Electron Microscopy Sciences, Hatfi eld, PA) in PBS. Samples were processed at the MSU Center for Advanced microscopy where they were postfi xed in 1% osmium tetroxide, rinsed in distilled water, dehydrated through a graded series of acetone, and embedded in epoxy resin. Ultrathin 70 nm sections were obtained and then analyzed and photographed using a JEOL 100CXII electron microscope. Pluripotency In Vitro Studies : The effects of exposure to AuNPs on the in vitro pluripotency capabilities of hESCs were determined using spontaneous differentiation of EBs. [ 65 ] Briefl y, EBs were generated by mechanical dissociation of hESC colonies and cultured for two weeks in FGF2-free hESC medium in presence of vehicle, 0.6 μg mL −1 AuNP1.5, or 10 μg mL −1 of AuNP4 and AuNP14. At the end of exposure, total RNA was extracted from EBs using Qiazol (Qiagen, Valencia, CA) according to the manufacturer's protocol, quantifi ed by optical density, and subjected to reverse transcription using Superscript II Reverse Transcriptase and random primers (Life Technologies Corporation, Carlsbad, CA) for 50 min at 40 °C followed by 15 min at 75 °C. Quantitative PCR analyses of the wellestablished lineage marker genes-endodermal ( AFP and NODAL ), ectodermal ( NCAM and NESTIN ), and mesodermal ( BRACHYURY , PITX2, and LEFTY )-were performed using an ABI PRISM 7000 Sequence Detection System and its software (Applied Biosystems) with 10 ng cDNA, 400 × 10 −9 M of each primers, and SYBR Green PCR Master Mix (Life Technologies Corporation, Carlsbad, CA). Resulting data were normalized against the expression of the internal control GAPDH gene. Data analysis was performed using the 2 − ΔΔ Ct method (Livak and Schmittgen 2001) and standardized by log transformation, mean centering, and autoscaling as previously described. [ 66 ] Data were collected from three separate experiments. Differentiation of hESCs into NPCs : Generation of NPCs from hESCs was performed as previously described. [ 64, 67 ] Exposure of hESC-Derived NPCs to AuNPs : hESCs-derived NPCs were cultured on fi bronectin-coated six-well dishes in N 2 /FGF2 medium and chronically exposed to vehicle or the different sized AuNPs for 72 h, at which time cells were fi xed and immunostained for Nestin and the DNA marker DAPI. The total number of Nestin-positive cells and DAPI-stained nuclei were counted in fi ve fi elds per well in three separate experiments, by an observer blind to the experimental conditions. The number of cells harboring pyknotic nuclei was also calculated. Total numbers were expressed as a percentage of the total number of cells, as evaluated by DAPI or Hoescht staining.
Neuronal Differentiation of hESC-Derived NPCs : Neuronal differentiation of NPCs derived from control and AuNP-exposed hESCs was achieved as previously described. [ 50, 64 ] NPCs were cultured on polyornithine/laminin-coated 12-well dishes at a 5105 cells cm Morphological Analysis of MAP2-Positive Cells : Determination of neuritic complexity of MAP2-positive cells derived from control and AuNP-exposed hESCs was performed using Sholl analysis, as previously described. [ 64, 68, 69 ] Neurons were randomly selected for which neurites could be clearly identifi ed and distinguished from neighboring cells. For each experimental condition, analysis of 18-27 neurons was performed blindly to well treatment. For each neuron examined, the average sum of crossings, the average maximal neuritic distance, and the average total number of branchings were recorded. Antibodies and Immunofl uorescence Procedures : Immunofl uorescence staining was performed as previously described. [ 70 ] Following fi xation in 4% paraformaldehyde, cells were rinsed in PBS, blocked in 3% donkey serum (Sigma-Aldrich, St Louis, MO) in 0.3% Triton-X-100 (NDST3%), and incubated overnight at 4 °C with the primary antibodies diluted in NDST1%. After several rinses in NDST1%, cells were incubated for 2 h in the dark with secondary anti-mouse antibodies conjugated to Alexa 488 (1:1000, Life Technologies Corporation, Carlsbad, CA). Following rinses, cells were stained with the nuclear marker DAPI (Sigma-Aldrich, St Louis, MO). Specifi city of the immunostainings was assessed by replacing the primary antibodies with normal serum, and by omitting one immunoreagent of the immunostaining protocol.
Statistical Analysis : Statistical signifi cance between experimental groups was determined by Student's t -test or one-way analysis of variance (ANOVA) followed by a post hoc Holm-Sidak test when F value was signifi cant, or Kruskal-Wallis one-way ANOVA on ranks followed by Dunn's test using the SigmaPlot 12 software (SYSTAT Software Inc., San Jose, CA). Statistical signifi cance was defi ned at p ≤ 0.05. Data are expressed as the mean ± SEM.
Immunoprecipitation Based Colometric Assays : Global DNA methylation status of exposed and control hESCs were determined using MethylFlash Methylated DNA Quantifi cation Kit (Catalogue No. P-1034) and MethylFlash Hydroxymethylated DNA Quantifi cation Kit (Catalogue No. P-1036) from Epigentek. Briefl y, 200 ng of DNA was bound to the bottom of pretreated wells and 5 hmC DNA was detected using sequential treatment with capture antibody and detection antibody. The fi nal colorimetric signal was normalized to the standard input DNA to estimate the overall methylation percentage.
Statistical Analysis of HM450K Data : The human methylation 450K array (HM450K) is capable of measuring CpG methylation at over 480 000 CpG sites. [ 71, 72 ] The percent methylation at the CpG sites is represented as beta values ranging from 0 to 1. [ 73 ] The beta or β for the i th interrogated CpG nucleotide is 
where y i,methy and y i,unmethy are the intensities measured by the i th methylated and unmethylated probes, respectively. Illumina recommends adding a constant offset α (by default, α = 100) to the denominator to regularize β value when both methylated and unmethylated probe intensities are low. For preprocessing and normalization of the HM450K data, the raw signal intensity fi les (.idat) for HM450K array were obtained. Quality control, background correction, and preprocessing of the data were carried out using the pipeline proposed by Teschendorff et al. [ 74 ] The preprocessed beta values were further corrected for Type1/Type2 probe bias. The Type 1 probes are composed of an unmethylated bead and a methylated bead. [ 75 ] If the bead for methylated DNA matches the target site there is a single base extension which results in detection which signals into the red channel. Similarly, if an unmethylated bead binds to the DNA it signals into the green channel. The Type 2 probes incorporate both the unmethylated and methylated bead type on a single probe and the ratio of incorporation of two differently colored fl uorescent nucleotides determines the methylation signal. The Type 1 probes have been shown to have more stable signal with less variability compared to the Type 2 probes. [ 76 ] Therefore to reconcile the differences between the Type 1 and Type 2 probes, we used a three-state beta mixture model (BMIQ) to normalize the data. [ 74 ] The preprocessing and the normalization pipeline was implemented using ChAMP package in R. The data were further corrected for batch effects using ComBat function in R and all known human SNP sites ( n = 92 667) were removed prior to differential methylation analysis. PCA was performed on the normalized beta matrix for visualization of differences in sample methylation profi le. Differential methylation analysis was performed using a fi xed effect model implemented using the R function "CpGassoc." [ 77 ] Supporting Information
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